These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27021761)

  • 1. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.
    Herdman M; Cole A; Hoyle CK; Coles V; Carroll S; Devlin N
    Value Health; 2016; 19(2):255-66. PubMed ID: 27021761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Utility and Disability Weights in Economic Evaluation of Pediatric Vaccines.
    Neppelenbroek NJM; de Wit GA; Dalziel K; Devlin N; Carvalho NI
    Value Health; 2023 Jul; 26(7):1098-1106. PubMed ID: 36967026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review and Meta-analysis of Childhood Health Utilities.
    Kwon J; Kim SW; Ungar WJ; Tsiplova K; Madan J; Petrou S
    Med Decis Making; 2018 Apr; 38(3):277-305. PubMed ID: 28990449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
    Ungar WJ
    Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Patient-Reported Outcomes in Pediatric Populations With Vaccine-Preventable Infectious Diseases: A Systematic Review of the Literature (the PROCHID Study).
    Herdman M; Hoyle CK; Coles V; Carroll S; Devlin N
    Value Health; 2016 Jan; 19(1):109-19. PubMed ID: 26797243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
    Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health state valuation in low- and middle-income countries: a systematic review of the literature.
    Kularatna S; Whitty JA; Johnson NW; Scuffham PA
    Value Health; 2013; 16(6):1091-9. PubMed ID: 24041360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease?
    Sullivan SM; Tsiplova K; Ungar WJ
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):599-607. PubMed ID: 27659998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing vaccines using value of statistical life measures.
    Laxminarayan R; Jamison DT; Krupnick AJ; Norheim OF
    Vaccine; 2014 Sep; 32(39):5065-70. PubMed ID: 25045822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in utility elicitation methods in cardiovascular disease: a systematic review.
    Blieden Betts M; Gandra SR; Cheng LI; Szatkowski A; Toth PP
    J Med Econ; 2018 Jan; 21(1):74-84. PubMed ID: 28899233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual Preferences for Child and Adolescent Vaccine Attributes: A Systematic Review of the Stated Preference Literature.
    Michaels-Igbokwe C; MacDonald S; Currie GR
    Patient; 2017 Dec; 10(6):687-700. PubMed ID: 28474295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mind the (inter-rater) gap. An investigation of self-reported versus proxy-reported assessments in the derivation of childhood utility values for economic evaluation: A systematic review.
    Khadka J; Kwon J; Petrou S; Lancsar E; Ratcliffe J
    Soc Sci Med; 2019 Nov; 240():112543. PubMed ID: 31586777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health status utilities in pediatrics: a systematic review of acute lymphoblastic leukemia.
    van Litsenburg RR; Kunst A; Huisman J; Ket JC; Kaspers GJ; Gemke RJ
    Med Decis Making; 2014 Jan; 34(1):21-32. PubMed ID: 23886678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh.
    Levin A; Levin C; Kristensen D; Matthias D
    Vaccine; 2007 Sep; 25(39-40):6945-57. PubMed ID: 17707556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of economic evaluation studies: are vaccination programs efficient in Spain?
    García-Altés A
    Vaccine; 2013 Mar; 31(13):1656-65. PubMed ID: 23370153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.